1. Home
  2. KYMR
  3. KYMR News

Latest Kymera Therapeutics Inc. (KYMR) News on May 29, 2024

Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting

GlobeNewswire

5 days ago

Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting

Thomson Reuters StreetEvents

3 months ago

Q4 2023 Kymera Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

7 months ago

Q3 2023 Lifestance Health Group Inc Earnings Call

Associated Press Finance

7 months ago

LifeStance Health: Q3 Earnings Snapshot

Share on Social Networks: